1. The programme for the eradication of Aujeszky’s disease presented by Belgium is hereby approved for the period from 1 January 2005 to 31 December 2005.
2. The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests to be incurred by Belgium for the programme referred to in paragraph 1, and shall not exceed EUR 300 000.
1. The programme for the eradication of Aujeszky’s disease presented by Spain is hereby approved for the period from 1 January 2005 to 31 December 2005.
2. The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests to be incurred by Spain for the programme referred to in paragraph 1, and shall not exceed EUR 250 000.
1. The programme for the eradication of Aujeszky’s disease presented by Hungary is hereby approved for the period from 1 January 2005 to 31 December 2005.
2. The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests to be incurred by Hungary for the programme referred to in paragraph 1, and shall not exceed EUR 50 000.
1. The programme for the eradication of Aujeszky’s disease presented by Ireland is hereby approved for the period from 1 January 2005 to 31 December 2005.
2. The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests to be incurred by Ireland for the programme referred to in paragraph 1, and shall not exceed EUR 50 000.
1. The programme for the eradication of Aujeszky’s disease presented by Portugal is hereby approved for the period from 1 January 2005 to 31 December 2005.
2. The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests to be incurred by Portugal for the programme referred to in paragraph 1, and shall not exceed EUR 25 000.
1. The programme for the eradication of Aujeszky’s disease presented by Slovakia is hereby approved for the period from 1 January 2005 to 31 December 2005.
2. The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests to be incurred by Slovakia for the programme referred to in paragraph 1, and shall not exceed EUR 25 000.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.